IP Library Granted Patent US 9,775,671
Granted Patent B2
US 9,775,671 · App. 15/221,504 · Granted Oct 3, 2017

Multi-layer electrode ablation probe and related methods

Inventor: Larry Azure (LaConner, WA)
Assignee: LaZure Scientific, Inc.
A61B18/1477A61B18/14A61B18/18A61N1/05A61B2017/00867A61B2018/0016A61B2018/143A61B2018/1407A61B2018/1425A61B2018/1432A61B2018/1475C08L2201/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,775,671
App. No.
15/221,504
Granted
Oct 3, 2017
Kind
B2
Abstract

Electric field delivery and ablation of target tissue regions, including cancerous cells and solid tumors. Methods and systems include delivering an electric field to a target tissue, and may include positioning a first electrode or plurality to at least partially define a first treatment volume in the target tissue; positioning a second electrode or plurality to at least partially define a second treatment volume, the first volume is disposed in the second volume; and establishing a first current flow extending through the first volume and a second current flow extending through the second volume.

Claims (15)

1. A method of delivering an electric field to a target tissue, comprising:

positioning a first electrode to at least partially define a first treatment volume in the target tissue;

positioning a second electrode to at least partially define a second treatment volume, wherein the first volume is disposed in the second volume;

establishing a first electric field extending within the first volume and a second electric field extending within the second volume; and

wherein the first electric field selectively destroys abnormally proliferating cells while leaving normal cells substantially intact within first treatment volume and the second electric field selectively destroys abnormally proliferating cells while leaving normal cells substantially intact within the second treatment volume.

2. The method of claim 1 , wherein the first electrode and the second electrode curve around a field center.

3. The method of claim 2 , wherein the field center comprises a central electrode positioned at about a location commonly central to the first and second volumes.

4. The method of claim 3 , wherein the first electric field extends between the central electrode and the first electrode.

5. The method of claim 3 , wherein the second electric field extends between the central electrode and the second electrode.

6. The method of claim 3 , wherein the second electric field extends between the first electrode and the second electrode.

7. The method of claim 1 , wherein establishing the first electric field destroys cancerous cells in the first volume.

8. The method of claim 7 , wherein cancerous cell destruction comprises low-power, mild hyperthermic tissue ablation.

9. The method of claim 8 , wherein the first electric field comprises a frequency between about 50 kHz and about 300 kHz, and an electric field strength less than about 50 V/cm.

10. The method of claim 1 , wherein the first electric field and second electric field are established sequentially and at different times.

11. The method of claim 1 , wherein the first electric field is established while the second electric field is established.

Continuity (4)
Continuation 14044756 · Oct 2, 2013
Division 12210942 · Sep 15, 2008
Provisional Application 60972708 · Sep 14, 2007
Related Publication 20170014179A1 · Jan 19, 2017